Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Blanchette

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Blood Reviews|March 27, 2002
Childhood chronic immune thrombocytopenic purpura (ITP)V Blanchette
Seminars in Hematology|August 15, 2000
Approach to the investigation and management of immune thrombocytopenic purpura in childrenV Blanchette, M Carcao
Transfusion Science|June 3, 1999
Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpuraV Blanchette, M Carcao
La Revue De Medecine Interne|January 16, 2021
[Multidisciplinary management of diabetic foot ulcer infection]V Blanchette, M Brousseau-Foley
Seminars in Hematology|April 2, 1998
Management of chronic immune thrombocytopenic purpura in children and adultsV Blanchette, J Freedman, B Garvey
Bailliere'S Clinical Haematology|October 1, 1990
Haematological investigation in neonatesV Blanchette, J Doyle, M Andrew
Journal of Thrombosis and Haemostasis : JTH|February 8, 2006
Are randomized clinical trials the only truth? Not alwaysL Aledort, R Ljung, V Blanchette, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Clinical trial design in haemophiliaD M Dimichele, V Blanchette, E Berntorp
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 1998
Isolated thrombocytopenic purpura associated with infection due to verocytotoxin (Shiga toxin)-producing Escherichia coli serotype O26:H11K Ludwig, M Petric, V Blanchette, et al.
Transfusion Medicine (Oxford, England)|April 30, 2005
Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatmentC Barnes, V Blanchette, P Canning, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Blood Reviews|March 27, 2002
Childhood chronic immune thrombocytopenic purpura (ITP)V Blanchette
Seminars in Hematology|August 15, 2000
Approach to the investigation and management of immune thrombocytopenic purpura in childrenV Blanchette, M Carcao
Transfusion Science|June 3, 1999
Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpuraV Blanchette, M Carcao
La Revue De Medecine Interne|January 16, 2021
[Multidisciplinary management of diabetic foot ulcer infection]V Blanchette, M Brousseau-Foley
Seminars in Hematology|April 2, 1998
Management of chronic immune thrombocytopenic purpura in children and adultsV Blanchette, J Freedman, B Garvey
Bailliere'S Clinical Haematology|October 1, 1990
Haematological investigation in neonatesV Blanchette, J Doyle, M Andrew
Journal of Thrombosis and Haemostasis : JTH|February 8, 2006
Are randomized clinical trials the only truth? Not alwaysL Aledort, R Ljung, V Blanchette, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Clinical trial design in haemophiliaD M Dimichele, V Blanchette, E Berntorp
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 1998
Isolated thrombocytopenic purpura associated with infection due to verocytotoxin (Shiga toxin)-producing Escherichia coli serotype O26:H11K Ludwig, M Petric, V Blanchette, et al.
Transfusion Medicine (Oxford, England)|April 30, 2005
Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatmentC Barnes, V Blanchette, P Canning, et al.
Pageof 11